|
dna metabolic process
|
GO:0006259 |
303 |
0.077
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.052
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.047
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.042
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.038
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.035
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.034
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.032
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.030
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.029
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.028
|
|
|
limb development
|
GO:0060173 |
166 |
0.028
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.027
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.026
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.026
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.026
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.026
|
|
|
neuron death
|
GO:0070997 |
154 |
0.025
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.025
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.025
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.024
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.024
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.024
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.024
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.023
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.023
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.023
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.022
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.022
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.022
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.022
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.021
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.021
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.021
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.021
|
|
|
regionalization
|
GO:0003002 |
337 |
0.021
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.021
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.020
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.020
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.019
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.019
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.019
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.019
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.019
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.019
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.019
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.019
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.019
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.018
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.018
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.018
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.018
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.018
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.018
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.018
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.018
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.018
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.018
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.018
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.018
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.018
|
|
|
rna processing
|
GO:0006396 |
105 |
0.017
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.017
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.017
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.017
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.017
|
|
|
cation transport
|
GO:0006812 |
399 |
0.017
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.017
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.017
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.017
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.017
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.016
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.016
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.016
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.016
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.016
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.016
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.016
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.016
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.016
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.015
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.015
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.015
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.015
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.015
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.015
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.015
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.015
|
|
|
action potential
|
GO:0001508 |
78 |
0.015
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.015
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.015
|
|
|
methylation
|
GO:0032259 |
134 |
0.015
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.015
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.015
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.015
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.014
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.014
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.014
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.014
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.014
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.014
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.014
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.014
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.014
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.014
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.014
|
|
|
ear development
|
GO:0043583 |
200 |
0.013
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.013
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.013
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.013
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.013
|
|
|
ossification
|
GO:0001503 |
216 |
0.013
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.013
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.013
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.013
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.013
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.013
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.013
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.013
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.013
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.013
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.013
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.013
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.013
|
|
|
placenta development
|
GO:0001890 |
140 |
0.013
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.012
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.012
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.012
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.012
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.012
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.012
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.012
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.012
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.012
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.012
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.012
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.012
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.012
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.012
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.012
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.012
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.012
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.012
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.012
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.012
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.012
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.012
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.011
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.011
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.011
|
|
|
histone modification
|
GO:0016570 |
159 |
0.011
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.011
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.011
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.011
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.011
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.011
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.011
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.011
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.011
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.011
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.011
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.011
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.011
|
|
|
segmentation
|
GO:0035282 |
93 |
0.011
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.011
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.011
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.011
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.011
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.011
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.011
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.011
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.011
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.011
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.011
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.011
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.011
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.011
|
|
|
cognition
|
GO:0050890 |
149 |
0.011
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.011
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.011
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.011
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.011
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.011
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.011
|
|
|
myelination
|
GO:0042552 |
74 |
0.011
|
|
|
regulation of mesenchymal cell proliferation involved in lung development
|
GO:2000790 |
2 |
0.010
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.010
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.010
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.010
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.010
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.010
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.010
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.010
|
|
|
kidney development
|
GO:0001822 |
213 |
0.010
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.010
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.010
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.010
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.010
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.010
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.010
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.010
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.010
|
|
|
gonad development
|
GO:0008406 |
141 |
0.010
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.010
|
|
|
telomere maintenance
|
GO:0000723 |
19 |
0.010
|
|